Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 25, 2000

View Archived Issues

Eurand expands drug delivery capabilities

NIAID signs agreement with MVI/PATH for malaria vaccine research

Pig small intestine submucosa shows efficacy in wound healing

Aquila receives milestone payments under licensing agreements

NK1 receptor antagonist CP-99994 tested in ferret model of emesis

Oxford BioMedica to collaborate with AstraZeneca in drug discovery

Phase III results positive for memantine in AD

New Videx capsule formulation approved in France

Nastech's intranasal apomorphine compared to Viagra in phase II pilot trial

Magainin to begin clinical program for squalamine in genetic bone disorder

Buccal insulin/metformin combination therapy tested in type II diabetes

SciClone awarded grant to study novel immunomodulator in TB

Combidex NDA accepted for FDA review

PathoGenesis announces approval, distribution agreement for TOBI

Abbott launches new sedative for ICU use only

Use of FK-506 as topical analgesic disclosed

Cytotoxic artemisinin derivatives designed at Hong Kong U. of Science & Technology

U. of Texas designs new DNA-cleaving compounds

Antianginal agents with minimal arrhythmogenic potential developed at Lafon

Small-molecule transthyretin amyloid fibril inhibitors emerge from structure-based design program

Kinetix enters research collaboration with Dana-Farber Cancer Institute

Beijing-based researchers discover new antitumor indole derivatives

Allergan and Dura enter commercialization agreement for multiple products

Antiplatelet agents under study at Chinese centers

BIBN-4096BS: an extremely potent and selective CGRP antagonist for migraine

Second orphan drug designation granted for Maxamine

Selective 5-HT1D agonist L-775606 has reduced coronary vasoconstrictor effects vs. sumatriptan

Popular Stories

23andme founder-led group outbids Regeneron for company
BioWorld
The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...
Today's news in brief
BioWorld
BioWorld briefs for June 17, 2025.
Elevidys’ second liver death hits Sarepta, sends DMD ripples
BioWorld
How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 17, 2025.
EACR 2025: Immune rewiring in cancer orchestrates tumor microenvironment
BioWorld Science
Among the presentations included in the Top Abstracts category at the recently inaugurated Annual Congress of the European Association for Cancer Research (EACR)...